Increasing evidence has suggested an important role for environmental toxins such as pesticides in the pathogenesis of Parkinson's disease (PD). Chronic exposure to rotenone, a common herbicide, reproduces features of Parkinsonism in rats. Mechanistically, rotenone-induced dopaminergic neurodegeneration has been associated with both its inhibition of neuronal mitochondrial complex I and the enhancement of activated microglia. Our previous studies with NADPH oxidase inhibitors, diphenylene iodonium and apocynin, suggested that NADPH oxidase-derived superoxide might be a major factor in mediating the microglia-enhanced rotenone neurotoxicity. However, because of the relatively low specificity of these inhibitors, the exact source of superoxide induced by rotenone remains to be further determined. In this study, using primary mesencephalic cultures from NADPH oxidase-null (gp91 phoxϪ/Ϫ ) or wild-type (gp91 phoxϩ/ϩ ) mice, we demonstrated a critical role for microglial NADPH oxidase in mediating microglia-enhanced rotenone neurotoxicity. In neuron-glia cultures, dopaminergic neurons from gp91 phoxϪ/Ϫ mice were more resistant to rotenone neurotoxicity than those from gp91 phoxϩ/ϩ mice. However, in neuron-enriched cultures, the neurotoxicity of rotenone was not different between the two types of mice. More importantly, the addition of microglia prepared from gp91 phoxϩ/ϩ mice but not from gp91 phoxϪ/Ϫ mice to neuronenriched cultures markedly increased rotenone-induced degeneration of dopaminergic neurons. Furthermore, apocynin attenuated rotenone neurotoxicity only in the presence of microglia from gp91 phoxϩ/ϩ mice. These results indicated that the greatly enhanced neurotoxicity of rotenone was attributed to the release of NADPH oxidase-derived superoxide from activated microglia. This study also suggested that microglial NADPH oxidase may be a promising target for PD treatment.
Introduction
Parkinson's disease (PD) is a movement disorder characterized by a progressive and selective degeneration of the nigrostriatal dopaminergic pathway (Olanow and Tatton, 1999) . Although its etiology remains unclear, many lines of evidence have indicated an environmental exposure basis for the disease. Living in a rural environment, farming, drinking well water, and occupational exposure to agricultural chemicals have been linked to nigrostriatal dopaminergic neurodegeneration (Rajput and Uitti, 1987; Semchuk et al., 1992; Liou et al., 1997; Priyadarshi et al., 2001) . A number of epidemiological and case-controlled studies have suggested a positive correlation between early exposure to pesticides and increased risk for PD (Liou et al., 1997; Gorell et al., 1998; Ritz and Yu, 2000; Herishanu et al., 2001) . Experimental evidence also indicates pesticides and/or related agrochemicals as risk factors for PD. Chronic systemic exposure to rotenone reproduces Parkinsonian features in rats (Betarbet et al., 2000; Alam and Schmidt, 2002) . Mechanistically, rotenone-induced degeneration of dopaminergic neurons may not be solely attributed to an impairment of neuronal mitochondrial complex I activity (Greenamyre et al., 1999; Jenner, 2001 ) but may also involve the participation of the resident immune cells in the brain, microglia (Gao et al., 2002a; Sherer et al., 2003) . Combined exposure to the herbicide paraquat and the fungicide maneb during both adult and postnatal periods results in lesions of the nigrostriatal dopaminergic system, and the developmental exposure enhances adult susceptibility to these pesticides (Thiruchelvam et al., 2000 (Thiruchelvam et al., , 2002 . In addition, there seems to be an interplay between environmental factors and genetic vulnerability, because several pesticides, including rotenone, dieldrin, and paraquat, have been reported to directly accelerate the rate of ␣-synuclein fibril formation that is associated with ␣-synuclein aggregation (Uversky et al., 2001 (Uversky et al., , 2002 . Moreover, various environmental factors may also work in concert to induce dopaminergic neurodegeneration. For example, nontoxic or minimally toxic concentrations of rotenone combined with the inflammogen lipopolysaccharide synergistically induced a selective degeneration of dopaminergic neurons in primary mesencephalic neuron-glia cultures (Gao et al., 2003) .
Recently, a number of studies have demonstrated that microglial activation, the hallmark of neuroinflammation, plays an important role in the pathogenesis of PD (Vila et al., 2001; Liu and Hong, 2003) . We reported that the presence of microglia mark-edly increased rotenone neurotoxicity, which was associated with the release of superoxide from activated microglia. Studies with NADPH oxidase inhibitors suggested that rotenone-induced extracellular superoxide production was catalyzed by NADPH oxidase (Gao et al., 2002a) . In that study, two mechanistically dissimilar inhibitors, diphenylene iodonium (DPI) and apocynin, were used to examine the involvement of NADPH oxidase, also called phagocyte oxidase (PHOX), in rotenone-induced neurodegeneration. However, the lack of specificity of these inhibitors, with the former inhibiting other flavoenzymes (Irani et al., 1997; Li and Trush, 1998) and the latter increasing ␥-glutamylcysteine synthetase activity (Lapperre et al., 1999) , calls for the determination of the exact source of the rotenone-induced superoxide production. In the current study, we used mesencephalic cultures from NADPH oxidase-null (gp91 phoxϪ/Ϫ ) or wild-type (gp91 phoxϩ/ϩ ) mice to directly test the critical role of microglial NADPH oxidase in mediating the elevated rotenone neurotoxicity.
Materials and Methods
Animals. Wild-type C57BL/6J (gp91 phoxϩ/ϩ ) and NADPH oxidase-null (gp91 phoxϪ/Ϫ ) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Breeding of the mice was conducted to achieve timed pregnancy with an accuracy of Ϯ0.5 d. Housing and breeding of the animals were performed in strict accordance with National Institutes of Health guidelines.
Primary mesencephalic neuron-glia cultures. Neuron-glia cultures were prepared from the ventral mesencephalic tissues of embryonic day 12 (E12)-E13 mice, as described previously (Gao et al., 2002a (Gao et al., , 2003 . Briefly, dissociated cells were seeded to 24 well (6 ϫ 10 5 /well) culture plates precoated with poly-D-lysine (20 g/ml) and maintained in 0.5 ml/well of minimum essential medium supplemented with 10% heatinactivated fetal bovine serum (FBS) and 10% heat-inactivated horse serum, 1 gm/l glucose, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 M nonessential amino acids, 50 U/ml penicillin, and 50 g/ml streptomycin. Cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. Cultures were replenished with fresh medium (0.5 ml/well) 3 d later. Seven-day-old cultures were used for treatment. Immunocytochemical analysis indicated that at the time of treatment, the cultures were made up of ϳ11% F4/80-immunoreactive (IR) microglia, 49% glial fibrillary acidic protein (GFAP)-IR astrocytes, and 40% neuron-specific nuclear protein (NeuN)-IR neurons, of which 2.5-3.5% were tyrosine hydroxylase (TH)-IR neurons. There was no significant difference in the composition of the neuron-glia cultures between gp91 phoxϪ/Ϫ and gp91 phoxϩ/ϩ mice. Mesencephalic neuron-enriched cultures. Neuron-enriched cultures were prepared from the ventral mesencephalic tissues of E12-E13 mice as described previously (Gao et al., 2002a) . Dissociated cells were first seeded at 6 ϫ 10 5 cells/well into poly-D-lysine-coated 24-well culture plates. Two days later, cytosine ␤-D-arabinofuranoside (8 -10 M) was added to suppress the proliferation of glial cells. Seven-day-old cultures that contained Ͻ0.1% F4/80-IR microglia and 10% GFAP-IR astrocytes were used for treatment. Of the NeuN-IR neurons, 2.5-3.5% were TH-IR neurons. In neuron-enriched cultures, the cell composition was not different between gp91 phoxϪ/Ϫ and gp91 phoxϩ/ϩ mice. Microglia-enriched cultures. Microglia were prepared from whole brains of 1-d-old mice as described previously (Liu et al., 2001) . After reaching confluence (14 d), microglia were separated from astrocytes by shaking the flasks for 5 hr at 150 rpm. The enriched microglia were Ͼ95% pure, as determined by immunostaining with antibodies against F4/80 and GFAP.
Immunocytochemistry. Immunostaining was performed as described previously Gao et al., 2003) with the following primary antibodies: anti-NeuN (1:2000; Chemicon, Temecula, CA), anti-F4/80 antigen (1:20; Serotec, Raleigh, NC), anti-GFAP (1:1000; Dako, Carpinteria, CA), and anti-TH (1:20,000; a gift from GlaxoSmithKline, Research Triangle Park, NC). Briefly, after blocking, formaldehyde-fixed cells were incubated overnight at 4°C with primary antibodies diluted in antibody diluent. The bound primary antibody was visualized by incubation with an appropriate biotinylated secondary antibody (Vector Laboratories, Burlingame, CA) followed by Vectastain ABC reagents (Vector Laboratories) and color development with 3,3Ј-diaminobenzidine. Images were recorded with a CCD camera and Metamorph software (Universal Imaging, West Chester, PA). For visual enumeration of the immunostained cells in cultures, 10 representative areas per well were counted. The overall dendrite length for individual TH-IR neurons was measured by following our previously published protocol (Gao et al., 2002a) . Three wells of identical treatment from each experiment and 50 TH-IR neurons per well were measured. Results were obtained from two separate experiments and were expressed as a percentage of the control cultures.
[ (Gao et al., 2002a) . Nonspecific uptake for DA was determined in the presence of 10 M mazindol.
Measurement of superoxide release. The release of superoxide was determined by measuring the superoxide dismutase (SOD)-inhibitable reduction of cytochrome c, as described previously Gao et al., 2002a) . Primary microglia (1 ϫ 10 5 /well), grown overnight in 96 well plates in DMEM containing 10% FBS, were switched to phenol red-free HBSS (100 l/well). Fifty microliters of HBSS containing vehicle or rotenone were then added to each well, followed by 50 l of ferricytochrome c (100 M) in HBSS, with and without 600 U/ml SOD. The cultures were incubated for 30 min at 37°C, and the absorbance at 550 nm was read with a SpectraMax Plus microplate spectrophotometer (Molecular Devices, Sunnyvale, CA). To determine the effect of the NADPH oxidase inhibitor apocynin on superoxide release, microglia were preincubated for 30 min with vehicle or apocynin before the addition of rotenone.
Statistical analysis. Statistical significance was assessed by ANOVA followed by Bonferroni's t test using the StatView program (Abacus Concepts, Berkeley, CA). A value of p Ͻ 0.05 was considered statistically significant.
Results
Rotenone induced a progressive and selective dopaminergic neurodegeneration, which was enhanced by glia Primary neuron-glia cultures were treated with 0.5-15 nM rotenone for 3 or 7 d, and the extent and selectivity of neurodegeneration were determined by multiple parameters. [ 3 H]DA uptake assays demonstrated a concentration-and time-dependent reduction in DA uptake ( Fig. 1 A) . Three days after treatment with rotenone, only the highest concentration of rotenone resulted in a significant reduction (37%) in DA uptake. As treatment time progressed, the reduction in DA uptake became more prominent. A 90% reduction was observed after treatment with 15 nM rotenone for 7 d, whereas 5 nM rotenone also caused a significant reduction in DA uptake. Immunocytochemical analysis illustrated that the progressive neurodegeneration induced by rotenone was selective to dopaminergic neurons (Fig. 1 B) . A significant decrease in the number of TH-IR neurons was seen in neuron-glia cultures treated for 7 d with 10 nM rotenone, whereas the decrease in NeuN-IR neurons was insignificant. The morphological analysis after immunocytochemical staining with antibodies against TH or NeuN indicated that rotenone neurotoxicity was selective to dopaminergic neurons (data not shown). Quantification of TH-IR and NeuN-IR neurons (Fig. 1 B) and morphological analysis verified that rotenone-induced reduction in DA uptake was attributed not to an alteration in dopamine transporter (DAT) but rather to dopaminergic neuronal death. Consistent with our published results from rats (Gao et al., 2002a) , the presence of microglia essentially increased rotenone neurotoxicity in mouse neuron-glia cultures (Fig. 1C) . For ex-ample, treatment for 7 d with 5 nM rotenone, which was a nontoxic concentration in neuron-enriched cultures, induced a significant reduction (30%) in DA uptake in neuron-glia cultures.
Dopaminergic neurons from gp91
phox؊/؊ mice were more resistant to rotenone neurotoxicity than those from gp91 phox؉/؉ mice in the neuron-glia culture system Neuron-glia cultures, prepared from either gp91 phoxϩ/ϩ or gp91 phoxϪ/Ϫ mice, were treated with 2.5-10 nM rotenone for 7 d, and dopaminergic neurodegeneration was determined by the measurement of [ 3 H]DA uptake, quantification of TH-IR neurons, or measurement of overall dendrite length of TH-IR neurons. As shown in Figure 2 A, rotenone decreased [ 3 H]DA uptake in a dose-dependent manner in both cell culture systems. However, the magnitude of decrease in the cultures from gp91 phoxϩ/ϩ mice was greater than that from gp91 phoxϪ/Ϫ mice. Consistent with the effect observed with the uptake assays, quantification of TH-IR neurons also demonstrated the resistance of dopaminergic neurons from gp91 phoxϪ/Ϫ mice to rotenone neurotoxicity (Fig. 2 B) . In addition, morphological analysis also illustrated that the number of TH-IR neurons in rotenone-treated cultures from gp91 phoxϩ/ϩ mice was significantly lower than that from gp91 phoxϪ/Ϫ mice, and that the dendritic network of rotenonetreated cultures from gp91 phoxϩ/ϩ mice was markedly less extensive compared with that from gp91 phoxϪ/Ϫ mice (Fig. 2C) . Quantification of TH-IR dendrite length also indicated the resistance of dopaminergic neurons from gp91 phoxϪ/Ϫ mice to rotenone neurotoxicity. Treatment for 7 d with 10 nM rotenone reduced the average dendrite length of TH-IR neurons from gp91 phoxϩ/ϩ mice to 25.8 Ϯ 10.5% of control cultures ( p Ͻ 0.001 compared with control), whereas the dendrite length of TH-IR neurons from gp91 phoxϪ/Ϫ mice was 73.2 Ϯ 8.7% of control cultures ( p Ͻ 0.01 compared with corresponding control; p Ͻ 0.01 compared with the reduction in the dendrite length of TH-IR neurons from gp91 phoxϩ/ϩ mice).
Microglia from gp91 phox؉/؉ but not gp91 phox؊/؊ mice enhanced rotenone-induced dopaminergic neurodegeneration In neuron-glia cultures, the resistance of dopaminergic neurons from gp91 phoxϪ/Ϫ mice to rotenone neurotoxicity supported the notion that the rotenone neurotoxicity was partially mediated by the activation of microglia and the NADPH oxidase-mediated release of superoxide free radical (Gao et al., 2002a Figure 3 , although the DA uptake of the neuronenriched cultures was not affected by the addition of microglia from gp91 phoxϪ/Ϫ mice, the addition of microglia from gp91 phoxϩ/ϩ mice significantly increased the sensitivity of dopaminergic neurons (either from gp91 phoxϩ/ϩ mice or from gp91 phoxϪ/Ϫ mice) to rotenone neurotoxicity. Furthermore, in the neuron-enriched culture system, the neurotoxicity of rotenone was not different between gp91 phoxϪ/Ϫ mice and gp91 phoxϩ/ϩ mice. Moreover, the addition of microglia from gp91 phoxϩ/ϩ mice equally decreased the capability of neuron-enriched cultures from both types of mice to uptake DA. These data additionally strengthened the notion that microglial NADPH oxidase, but not neuronal NADPH oxidase, was responsible for the NADPH oxidase-mediated neurotoxicity of rotenone.
Rotenone-induced release of superoxide from activated microglia was mediated by NADPH oxidase We reported that activated microglia elevated rotenone neurotoxicity in rat cell cultures through the release of superoxide free radical (Gao et al., 2002a) . The results described above indicated that microglial NADPH oxidase plays a pivotal role in microgliaenhanced rotenone neurotoxicity. Indeed, as shown in Figure 4 , rotenone stimulated microglia from gp91 phoxϩ/ϩ mice to release superoxide free radical, which was attenuated by an inhibitor of NADPH oxidase, apocynin. In sharp contrast, microglia from gp91 phoxϪ/Ϫ mice failed to release superoxide free radical after the stimulation with rotenone. We observed similar profiles for the inhibition of superoxide production when using another inhibitor of NADPH oxidase, DPI (data not shown). In addition, in neuron-enriched cultures, superoxide production was undetectable (data not shown). These results indicated that the resistance of dopaminergic neurons of gp91 phoxϪ/Ϫ mice was attributable to the lack of superoxide release by microglia from gp91 phoxϪ/Ϫ mice.
Apocynin protected dopaminergic neurons against rotenone neurotoxicity only in the presence of microglia from gp91 phox؉/؉ mice The relevance of rotenone-stimulated superoxide release in mediating microglia-enhanced rotenone neurotoxicity was established by the observation that inhibition of NADPH oxidase afforded neuroprotection (Fig. 5) . Pretreatment of neuron-glia cultures from gp91 phoxϩ/ϩ mice with 0.5 mM apocynin significantly attenuated the rotenone-induced degeneration of dopaminergic neurons measured either by [ 3 H]DA uptake (Fig. 5A ) or by counts of TH-IR neurons (Fig. 5B) . However, apocynin failed to protect dopaminergic neurons of gp91 phoxϪ/Ϫ mice against rotenone neurotoxicity (Fig. 5A) . Additionally, the neu- roprotective effect of apocynin was dependent on the presence of microglia from gp91 phoxϩ/ϩ mice: in neuron-enriched cultures from gp91 phoxϩ/ϩ mice, apocynin did not protect dopaminergic neurons against rotenone neurotoxicity, but did so quite effectively in neuron-glia cultures (Fig. 5C ). We did not use DPI to determine the neuroprotective effect, because of its neurotoxicity in our long-term cell cultures (Gao et al., 2002a,b) . These results gave strong support to the notion that the microglia-enhanced degeneration of dopaminergic neurons induced by rotenone was mediated by microglial NADPH oxidase.
Discussion
Our previous studies with NADPH oxidase inhibitors (DPI and apocynin) have suggested that microglia, via the release of NADPH oxidase-derived superoxide, markedly enhanced rotenone-induced degeneration of dopaminergic neurons. However, because of the relatively low specificity of these two inhibitors, the exact source of rotenone-induced extracellular superoxide production remained to be determined. In this study, using primary neuron-enriched and neuron-glia cultures from the mesencephalon of gp91 phoxϪ/Ϫ mice or gp91 phoxϩ/ϩ mice, we demonstrated that the microglia-enhanced rotenone neurotoxicity was attributed to microglial NADPH oxidase-mediated release of superoxide free radical. The presence of microglia from gp91 phoxϩ/ϩ mice rendered dopaminergic neurons more sensitive to rotenone neurotoxicity. Rotenone stimulated microglia from gp91 phoxϩ/ϩ mice to release superoxide, but it failed to do so in microglia from gp91 phoxϪ/Ϫ mice. Furthermore, apocynin significantly attenuated rotenone neurotoxicity only in the presence of microglia from gp91 phoxϩ/ϩ mice. These results indicated phoxϩ/ϩ mice but not gp91 phoxϪ/Ϫ mice. Mouse primary microglia were seeded to 96 well plates. After 24 hr, microglia were pretreated with vehicle or 0.5 mM apocynin for 30 min. Afterward, microglia were stimulated with rotenone (5 or 10 nM) or corresponding vehicle. Superoxide production, measured as SOD-inhibitable cytochrome c reduction, was determined as described in Materials and Methods. There was no significant difference in the basal levels of superoxide production (control) between the cultures from gp91 phoxϪ/Ϫ mice and those of their wild-type littermates. Results are a percentage of the control cultures and are expressed as means Ϯ SEM of three experiments performed in triplicate. **p Ͻ 0.005 compared with the control.
ϩϩ p Ͻ 0.005 compared with corresponding rotenone-treated cultures.
that rotenone-induced activation of microglia and the release of NADPH oxidase-derived superoxide from activated microglia mediated the greatly enhanced dopaminergic neurodegeneration induced by rotenone.
Neuroinflammation, as an integral component of the progressive neurodegenerative process, has been increasingly implicated in the pathogenesis of PD. Microglial activation, a hallmark of neuroinflammation, has been detected frequently in PD patients and experimental animal models. Our recent work demonstrated that the presence of microglia markedly enhanced rotenone neurotoxicity, and that rotenone-stimulated microglial activation preceded dopaminergic neurodegeneration (Gao et al., 2002a) . Similar to our in vitro observations, Sherer et al. (2003) reported recently that chronic rotenone exposure causes extensive microglial activation in the striatum and substantia nigra of the rat, with less activation of microglia in the cortex. They have also demonstrated that microglial activation occurs even in the absence of detectable nigrostriatal dopaminergic neurodegeneration and becomes more evident with the development of dopaminergic neurodegeneration.
Microglia play a pivotal role in the detection of invading pathogens, host defense, and tissue repair (Kreutzberg, 1996; Aloisi, 1999) . In response to immunological challenges or injury, microglia become readily activated and produce a variety of proinflammatory and neurotoxic factors, including tumor necrosis factor-␣, interleukin-1␤, eicosanoids, nitric oxide, and superoxide (Cassarino et al., 1997; Liu et al., 2002; Liu and Hong, 2003) . Although a few of these factors are thought to contribute to tissue repair (Streit et al., 1988) , the majority are believed to induce or exacerbate neurodegeneration through mechanisms not yet fully understood (McGeer et al., 1988; Minghetti and Levi, 1998; Liu and Hong, 2003) . Among the various cytotoxic factors released by activated microglia, reactive oxygen species (ROS) such as superoxide free radical appear to play a key role in the inflammation-mediated oxidative damage to neurons. Specifically, microglia-enhanced rotenone neurotoxicity was primarily mediated by NADPH oxidase-mediated release of superoxide, as evidenced by the significant release of superoxide by activated microglia, which was inhibitable by NADPH oxidase inhibitors and the essential neuroprotective effect of pharmacological inhibition and genetic inactivation of NADPH oxidase.
NADPH oxidase is an enzyme that is a major source of extracellular superoxide in immune cells, including microglia. This enzyme is a multisubunit enzymatic complex. Currently, at least seven subunits have been reported to be involved in NADPH oxidase assembly. In resting immune cells, these NADPH oxidase subunits are segregated into cytoplasmic and plasma membrane compartments. In response to stimuli, the cytosolic subunits (p47 PHOX , p67 PHOX , and p40 PHOX ) translocate to the membrane and associate with membrane components (gp91 PHOX and p22 PHOX ) to assemble the functional oxidase and subsequently release superoxide free radical (DeLeo and Quinn, 1996; Babior, 1999) . Two small G-proteins, Rac-1 and Rap1A, are also associated with the activation process of NADPH oxidase. The ability of immune cells, especially phagocytes, to generate prodigious quantities of superoxide anions is one of the main methods by which phagocytes kill invading pathogens. Although NADPH oxidase is primarily expressed in phagocytic cells, increasing evidence suggests that various subunits of NADPH oxidase are also expressed in nonphagocytic cells such as sympathetic ganglion neurons and cortical neurons (Fukui et al., 1995; Noh and Koh, 2000; Tammariello et al., 2000) , which suggests the possibility that neurons in general may express NADPH oxidase. However, we illustrated that neuronal NADPH oxidase was not directly involved in the production of superoxide or the induction of dopaminergic neurodegeneration induced by rotenone, based on several observations. First, in neuronenriched cultures, rotenone failed to induce superoxide release. Second, in the neuron-enriched culture system, the neurotoxicity of rotenone was not different between gp91 phoxϪ/Ϫ mice and gp91 phoxϩ/ϩ mice (Fig. 3) . Third, the addition of microglia, either from gp91 phoxϪ/Ϫ mice or from gp91 phoxϩ/ϩ mice, to neuron-enriched cultures did not affect this trend (Fig. 3) . Fourth, in the cultures from gp91 phoxϩ/ϩ mice, apocynin could not attenuate rotenone neurotoxicity in the absence of glia, but did so quite effectively in the presence of glia (Fig. 5) . Together, these data suggest that microglial NADPH oxidase, but not neuronal NADPH oxidase, renders dopaminergic neurons more sensitive to rotenone neurotoxicity. Additionally, two mechanistically dissimilar inhibitors of NADPH oxidase were used to confirm that the extracellular superoxide production we measured was catalyzed by NADPH oxidase: DPI directly inhibits the catalytic activity of the enzyme (Irani et al., 1997) , and apocynin prevents the assembly of the multisubunit enzyme complex (Stolk et al., 1994) .
Superoxide and its downstream products (hydroxyl radicals, singlet oxygen species, and hydrogen peroxide) are quite reactive and can interact with proteins, DNA, or RNA to alter their functions or induce lipid peroxidation, leading to eventual cell death (Facchinetti et al., 1998) . However, superoxide cannot directly cross cellular membranes (Halliwell, 2001) , making it unlikely that microglia-derived extracellular superoxide would enter neurons and directly trigger intraneuron toxic events. Alternatively, superoxide may convert to membrane-permeable hydrogen peroxide or perhaps other downstream products in the extracellular space, which, in turn, can cross the cell membrane and cause direct injury to neurons. Of the various populations of neurons in the brain, dopaminergic neurons are uniquely vulnerable to oxidative stress because of their innate characteristics, including reduced antioxidant capacity, increased accumulation of iron, and the high concentration of neurochemicals such as dopamine that are prone to oxidative modification (Jenner, 1998; Greenamyre et al., 1999) . Furthermore, it has been proposed that extracellular ROS appear to promote the mitochondriamediated generation of intracellular ROS (Turrens and Boveris, 1980; Hasegawa et al., 1990) . Thus, microglia-originated superoxide induced by rotenone, via formation of membranepermeable downstream products, might damage dopaminergic neurons directly or promote neuronal mitochondria-originated free radical production, which was a result of the inhibition of mitochondria complex I by rotenone. Indeed, one of the downstream products of superoxide, hydrogen peroxide, has been reported to result in cytochrome c release from mitochondria, caspase-3 activation, and apoptosis of human neuroblastoma cells. Moreover, chronic exposure to a low concentration of rotenone potentiates hydrogen peroxide-induced caspasedependent cell death (Sherer et al., 2002) . Therefore, the combination of the intrinsic characteristics of dopaminergic neurons and their physical location in a microglia-rich microenvironment (Lawson et al., 1990; Kim et al., 2000) renders them more sensitive to attacks by free radicals generated both extracellularly and intracellularly. The present study demonstrated that microglia-enhanced degeneration of dopaminergic neurons induced by rotenone was mediated by the activation of microglia and by the consequent release of microglial NADPH oxidase-mediated superoxide. This study also suggests that NADPH oxidase may be a promising target for PD treatment, especially in halting the progression of PD.
